Endothelial cell binding coatings for rapid encapsulation of bioerodable stents

Patent Citations (429)

Non-Patent Literature (69)

• International Search Report for PCT/US2006/017714 filed May 4, 2006, mailed Mar. 28, 2007, 18 pgs.Applicant
• Murayama et al., “Ion Implantation and Protein Coating of Detachable Coils for Endovascular Treatment of Cerebral Aneurysms: Concepts and Preliminary Results in Swine Models”, Neurosurgery, vol. 40, No. 6 (1997) pp. 1233-1244.Applicant
• Anonymous, Cardiologists Draw—Up the Dream Stent, Clinica 710:15 (Jun. 17, 1996), http://www.dialogweb.com/cgi/document?req=1061848202959, printed Aug. 25, 2003 (2 pages).Applicant
• Anonymous, Heparin-coated stents cut complications by 30%, Clinica 732:17 (Nov. 18, 1996), http://www.dialogweb.com/cgi/document?req=1061847871753, printed Aug. 25, 2003 (2 pages).Applicant
• Anonymous, Rolling Therapeutic Agent Loading Device for Therapeutic Agent Delivery or Coated Stent (Abstract 434009), Res. Disclos. pp. 974-975 (Jun. 2000).Applicant
• Anonymous, Stenting continues to dominate cardiology, Clinica 720:22 (Sep. 2, 1996), http://www.dialogweb.com/cgi/document?req=1061848017752, printed Aug. 25, 2003 (2 pages).Applicant
• Aoki et al., Endothelial Progenitor Cell Capture by Stents Coated With Antibody Against CD34, The HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry, J Am Coll Cardiol 45:1574-1579 (2005).Applicant
• Aoyagi et al., Preparation of cross-linked aliphatic polyester and application to thermo-responsive material, Journal of Controlled Release 32:87-96 (1994).Applicant
• Asahara et al., Isolation of Putative Progenitor Endothelial Cells for Angiogenesis, Science 275:964-967 (Feb. 14, 1997).Applicant
• Barath et al., Low Dose of Antitumor Agents Prevents Smooth Muscle Cell Proliferation After Endothelial Injury, JACC 13(2): 252A (Abstract) (Feb. 1989).Applicant
• Barbucci et al., Coating of commercially available materials with a new heparinizable material, J. Biomed. Mater. Res. 25:1259-1274 (Oct. 1991).Applicant
• Blindt et al., A novel drug-eluting stent coated with an integrin-binding cRGD peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells (draft manuscript for publication).Applicant
• Blindt et al., Abciximab Inhibits the Migration and Invasion Potential of Human Coronary Artery Smooth Muscle Cells, J Mol Cell Cardiol 32:2195-2206 (2000).Applicant
• Blindt et al., Downregulation of N-cadherin in the neointima stimulates migration of smooth muscle cells by RhoA deactivation, Cardiovascular Research 62:212-222 (2004).Applicant
• Blindt et al., Expression Patterns of Integrins on Quiescent and Invasive Smooth Muscle Cells and Impact on Cell Locomotion, J Mol Cell Cardiol 34:1633-1644 (2002).Applicant
• Chung et al., Inner core segment design for drug delivery control of thermo-responsive polymeric micelles, Journal of Controlled Release 65:93-103 (2000).Applicant
• Deb et al., Integrin Profile and In-Vivo Homing of Human Smooth Muscle Progenitor Cells, Circulation 110:2673-2677 (2004).Applicant
• Dev et al., Kinetics of Drug Delivery to the Arterial Wall Via Polyurethane-Coated Removable Nitinol Stent: Comparative Study of Two Drugs, Catheterization and Cardiovascular Diagnosis 34:272-278 (1995).Applicant
• Dichek et al., Seeding of Intravascular Stents with Genetically Engineered Endothelial Cells, Circ. 80(5):1347-1353 (Nov. 1989).Applicant
• Eigler et al., Local Arterial Wall Drug Delivery from a Polymer Coated Removable Metallic Stent: Kinetics, Distribution, and Bioactivity of Forskolin, JACC, 4A (701-1), Abstract (Feb. 1994).Applicant
• Fattori, Drug-eluting stents in vascular intervention, The Lancet, 361:247-249 (2003).Applicant
• Giancotti et al., Integrin Signaling, Science 285:1028-1032 (1999).Applicant
• Grube et al., TAXUS I: Six-and Twelve-Month Results From a Randomized, Doubled-Blind Trial on a Slow- Release Paclitaxel-Eluting Stent for De Novo Coronary Lesions, Circulation 107:38-42 (2003).Applicant
• Helmus, Overview of Biomedical Materials, MRS Bulletin, pp. 33-38 (Sep. 1991).Applicant
• Herdeg et al., Antiproliferative Stent Coatings: Taxol and Related Compounds, Semin. Intervent. Cardiol. 3:197-199 (1998).Applicant
• Hill et al., Circulating Endothelial Progentitor Cells, Vascular Function, and Cardiovascular Risk, New England Journal of Medicine 348:593-600(2003).Applicant
• Hill et al., Drug-eluting stents: an early systemic review to inform policy, Eur Heart Journal 25:902-919 (2004).Applicant
• Hristov et al., Endothelial Progenitor Cells, Mobilization, Differentiation, and Homing, Arterioscler Thromb. Vasc Biol 23:1185-1189 (2003).Applicant
• Huang et al., Biodegradable Polymers Derived from Aminoacids, Macromol. Symp. 144, 7-32 (1999).Applicant
• Inoue et al., An AB block copolymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs, Journal of Controlled Release 51:221-229 (1998).Applicant
• Kapur et al., Cross-talk between α4β1/α5β1 and c-Kit results in opposing effect on growth and survival of hematopoietic cells via the activation of focal adhesion kinase, mitogen-activated protein kinase, and Akt signaling pathways, Blood 97:1975-1981 (2001).Applicant
• Kataoka et al., Block copolymer micelles as vehicles for drug delivery, Journal of Controlled Release 24:119-132 (1993).Applicant
• Katsarava et al., Amino Acid-Based Bioanalogous Polymers. Synthesis and Study of Regular Poly(ester amide)s Based on Bis(α-amino acid)α,ω-Alkylene Diesters, and Aliphatic Dicarbolic Acids, Journal of Polymer Science Part A: Polymer Chemistry, 37(4), 391-407 (1999).Applicant
• Kipshidze et al., Role of the Endothelium in Modulating Neointimal Formation, Vasculoprotective Approaches to Attenuate Restenosis After Percutaneous Coronary Interventions, Journal of Am Coll Cardiol 44:733-739 (2004).Applicant
• Levy et al., Strategies for Treating Arterial Restenosis Using Polymeric Controlled Release Implants, Biotechnol. Bioact. Polym. [Proc. Am. Chem. Soc. Symp.], pp. 259-268 (1994).Applicant
• Liehn et al, Blockade of Keratinocyte-Derived Chemokine Inhibits Endothelial Recovery and Enhances Plaque Formation After Arterial Injury in Apoe-Deficient Mice, Arterioscler Thromb Vasc Biol 24:1891-1896 (2004).Applicant
• Liu et al., Drug release characteristics of unimolecular polymeric micelles, Journal of Controlled Release 68:167-174 (2000).Applicant
• Marconi et al., Covalent bonding of heparin to a vinyl copolymer for biomedical applications, Biomaterials 18(12):885-890 (1997).Applicant
• Matsumaru et al., Embolic Materials For Endovascular Treatment of Cerebral Lesions, J. Biomater. Sci. Polymer Edn 8(7):555-569 (1997).Applicant
• Miyazaki et al., Antitumor Effect of Implanted Ethylene-Vinyl Alcohol Copolymer Matrices Containing Anticancer Agents on Ehrlich Ascites Carcinoma and P388 Leukemia in Mice, Chem. Pharm. Bull. 33(6) 2490-2498 (1985).Applicant
• Miyazawa et al., Effects of Pemirolast and Tranilast on Intimal Thickening After Arterial Injury in the Rat, J. Cardiovasc. Pharmacol., pp. 157-162 (1997).Applicant
• Mogford et al., Vascular Smooth Muscle αvβ3 Integrin Mediates Arterior Vasodilation in Response to RGD Peptides, Circ Res 79:821-826 (1996).Applicant
• Moses et al., Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery, New England Journal of Medicine 349:1315-1325 (2003).Applicant
• Nordrehaug et al., A novel biocompatible coating applied to coronary stents, EPO Heart Journal 14, p. 321 (P1694), Abstr. Suppl. (1993).Applicant
• Ohsawa et al., Preventive Effects of an Antiallergic Drug, Pemirolast Potassium, on Restenosis After Percutaneous Transluminal Coronary Angioplasty, American Heart Journal 136(6):1081-1087 (Dec. 1998).Applicant
• Ozaki et al., New Stent Technologies, Progress in Cardiovascular Diseases, vol. XXXIX(2):129-140 (Sep./Oct. 1996).Applicant
• Pechar et al., Poly(ethylene glycol) Multiblock Copolymer as a Carrier of Anti-Cancer Drug Doxorubicin, Bioconjucate Chemistry 11(2):131-139 (Mar./Apr. 2000).Applicant
• Peled et al., The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34+ cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice, Blood 95:3289-3296 (2000).Applicant
• Peng et al., Role of polymers in improving the results of stenting in coronary arteries, Biomaterials 17:685-694 (1996).Applicant
• Pierschbacher et al., Influence of Stereochemistry of the Sequence Arg-Gyl-Asp-Xaa on Binding Specificity in Cell Adhesion, J Biol Chem 262:17294-17298 (1987).Applicant
• Regar et al., Angiographic Findings of the Multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL), Sirolimus-Eluting Stents Inhibit Restenosis Irrespective of the Vessel Size, Circulation 106:1949-1956 (2002).Applicant
• Ross, Antherosclerosis is an inflammatory disease, American Heart Journal 138:S419-S-420 (1999).Applicant
• Saotome, et al., Novel Enzymatically Degradable Polymers Comprising α-Amino Acid, 1,2-Ethanediol, and Adipic Acid, Chemistry Letters, pp. 21-24, (1991).Applicant
• Shigeno, Prevention of Cerebrovascular Spasm By Bosentan, Novel Endothelin Receptor, Chemical Abstract 125:212307 (1996).Applicant
• Shintani et al., Mobilization of Endothelial Progenitor Cells in Patients with Acute Myocardial Infarction, Circulation 103:2776-2779 (2001).Applicant
• Stone et al., One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent, The TAXUS-IV Trial, Circulation 109:1942-1947 (2004).Applicant
• Suzuki et al, Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model, Circulation 104:1188-1193 (2001).Applicant
• van Beusekom et al., Coronary stent coatings, Coronary Artery Disease 5(7):590-596 (Jul. 1994).Applicant
• Virmani et al., Drug eluting stents: are humans and animals studies comparable? Heart 89:133-138 (2003).Applicant
• Vogt et al., Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent, Eur Heart Journal 25:1330-1340 (2004).Applicant
• Walter et at, Local Gene Transfer of PhVEGF-2 Plasmid by Gene-Eluting Stents, an Alternative Strategy for Inhibition of Restenosis, Circulation 110:36-45 (2004).Applicant
• Walter et al., Statin Therapy Accelerates Reendothelialization, A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells, Circulation 105:3017-3024 (2002).Applicant
• Weber et al., Differentiation immobilization and hierarchical involvement of chemokines in monocyte arrest transmigration on inflamed endotheliem in shear flow, Eur J. Immunol 29:700-712 (1999).Applicant
• Weber et al., Sequential Regulation of α4β1 and α5β1 Integrin Avidity by CC Chemokines in Monocytes: Implications for Transendothelial Chemotaxis, J Cell Biol 134:1063-1073 (1996).Applicant
• Werner et al., Bone Marrow-Derived Progenitor Cells Modulate Vascular Vascular Reendothelialization ano Neointimal Formation, Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition, Artrioscler Throm Vasc Biol 22:1567-1572 (2002).Applicant
• Werner et al., Intravenous Transfusion of Endothelial Progenitor Cells Reduces Neointima Formation After Vascular Injury, Circ Res 93:e17-e24 (2003).Applicant
• Wilensky et al., Methods and Devices for Local Drug Delivery in Coronary and Peripheral Arteries, Trends Cardiovasc. Med. 3(5):163-170 (1993).Applicant
• Yokoyama et al., Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor, Journal of Controlled Release 50:79-92 (1998).Applicant
• Zeiffer et al., Neointimal Smooth Muscle Cells Display a Proinflammatory Phenotype Resulting in Increased Leukocyte Recruitment Medicated by P-Selectin and Chemokines, Circ Res 94:776-784 (2004).Applicant